Skip to content

The clinical efficacy of acupoint injection in the treatment of blood stasis syndrome of discogenic low back pain with Modic changes and its influence on related inflammatory factors

The clinical efficacy of acupoint injection in the treatment of blood stasis syndrome of discogenic low back pain with Modic changes and its influence on related inflammatory factors

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025002084
Enrollment
Unknown
Registered
2025-10-28
Start date
2024-01-01
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

discogenic low back pain

Interventions

Research group:Injection of Salvia miltiorrhiza at Jiaji points combined with oral Celecoxib

Sponsors

Guangdong Provincial Hospital of Integrated Traditional Chinese and Western Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Meets the diagnostic criteria of Western medicine and traditional Chinese medicine; 2. One or more vertebral bodies with Type 1 or Type 2 Modic changes, with the affected segment being L3-S1; 3. Minimum ODI score of 30 points (out of 100) and minimum VAS score of 4 cm (on a 10 cm scale); 4. Age between 18-75 years, gender; 5. If previously received other conservative treatments, a washout period of more than 7 days is required; 6. Participants who have been informed about the study and have signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with other severe diseases (e.g., cardio-cerebrovascular diseases and hepato-renal system diseases) that may affect the observation of therapeutic effects; 2. Patients with other degenerative disc-related diseases (e.g., lumbar disc herniation, lumbar spinal stenosis, etc.); 3. Patients allergic to the drugs used in this study; 4. Patients with mental disorders who may have difficulty cooperating with treatment; 5. Pregnant or breastfeeding women; 6. Patients with severe symptoms who are not suitable for conservative treatment.

Design outcomes

Primary

MeasureTime frame
TNF-a;IL-6;

Secondary

MeasureTime frame
Visual Analog Scale;Lumbar Spine Dysfunction Index;Traditional Chinese Medicine Syndrome Scoring Criteria;

Countries

China

Contacts

Public ContactHuang Weichang

Guangdong Provincial Hospital of Integrated Traditional Chinese and Western Medicine

huangwc1977@sina.com13928633070

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026